Testing a new PET dye for bladder tumor imaging
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new type of PET scan dye to see how well it shows bladder tumors. It may help doctors get clearer images without needing extra biopsies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 84 years old.
- You have a bladder tumor seen on a cystoscopy exam.
- You are willing to follow the study schedule.
- You are not pregnant or breastfeeding.
- You do not have severe liver or kidney problems.
- You are not allergic to the study imaging dye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET scan that uses a special antibody to find a marker called Trop2 on many common solid tumors. It may help doctors see tumors more clearly without needing a biopsy.
This study uses a special PET scan (a type of imaging) to look at tumors in people with pancreatic, lung, or bowel cancer. The scan uses a new tracer that may help doctors see cancer more clearly.
This trial tests a new type of PET/CT scan that uses a special tracer (called ⁶⁸Ga-FXX489) to help find and diagnose cancers. It is for people who are strongly suspected to have cancer and want to see if this new imaging method can help their doctors learn more about their disease.
This trial studies a special PET/CT scan tracer that is designed to bind to a protein (Nectin-4) found in some bladder cancers. It aims to help doctors see and stage tumors more clearly, which could improve diagnosis and treatment planning.
This study tests a new PET scan tracer that targets a protein called Nectin-4, which is found on some cancer cells. It aims to improve how doctors detect and monitor cancers like bladder, breast, and lung cancer. If you have one of these cancers, this scan might help your doctor see your cancer more clearly.
This study tests a new type of imaging agent (called a tracer) that helps PET scans see tumors more clearly. It may help doctors find and monitor cancer better.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.